Organon Partners With HUYA To Identify And Develop Chinese Biopharmaceuticals
Organon Partners With HUYA To Identify And Develop Chinese Biopharmaceuticals
Collaboration looks for opportunities to expand the Organon biotech research programs and facilitate links with China’s biotech industry
Oss, The Netherlands and San Diego, USA – January 9, 2007 — Organon, the human healthcare business of Akzo Nobel (Nasdaq: AKZOY), announced today that it has signed a collaboration agreement with HUYA Bioscience International, LLC, (HUYA) to search for new, proprietary biopharmaceuticals or pharmaceutical compounds.